New

PAREXEL

The AI engine Fit Assessment

Beta

PAREXEL develops digital solutions and operates within the pharmaceutical industry, providing a wide range of services to support drug development.

Blurb

PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide.

HQ Location

Waltham (United States)

Founded

1983

Employees

10000+

Total funding raised

$8.50B

Funding Status

Acquired by EQT, July 2021

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award.



Community Guidelines



Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are:



• Abusive, harassing or threatening to others.

• Defamatory, offensive, obscene, vulgar or depicting violence.

• Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs.

• Sexually explicit or pornographic.

• Fraudulent, deceptive, libelous, misleading or unlawful.

• Referencing criminal or illegal activity.

• Spamming.



We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.